Valuation Integra LifeSciences Holdings Corporation

Stocks

Market Closed - Nasdaq 23:00:00 22/09/2026 +03			5-day change	1st Jan Change
16.02 ^USD	+2.76%		+2.10%	+28.99%

09-16	Integra LifeSciences Holdings Corporation Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-15-2026 04:05 PM
07-30	BMO Cuts Price Target on Integra LifeSciences Holdings to $18 From $19, Keeps Market Perform Rating	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	5,674	4,683	3,405	1,750	967.4	1,246	-	-
Change	-	-17.47%	-27.3%	-48.6%	-44.72%	28.79%	-	-
Enterprise Value (EV) ¹	6,707	5,670	4,605	3,285	2,563	2,735	2,531	2,310
Change	-	-15.47%	-18.78%	-28.66%	-21.98%	6.72%	-7.47%	-8.71%
P/E	33.8x	26x	51.8x	-252x	-1.84x	25x	12.9x	9.86x
PBR	3.37x	2.6x	2.14x	1.13x	0.93x	1.07x	0.95x	0.85x
PEG	-	2.86x	-0.8x	2x	-0x	-0x	0.1x	0.3x
Capitalization / Revenue	3.68x	3.01x	2.21x	1.09x	0.59x	0.74x	0.72x	0.7x
EV / Revenue	4.35x	3.64x	2.99x	2.04x	1.57x	1.63x	1.46x	1.29x
EV / EBITDA	16.7x	13.8x	12.5x	10.2x	8.07x	7.94x	6.97x	5.99x
EV / EBIT	21.4x	15.5x	14x	11.7x	9.33x	9.19x	8.01x	6.87x
EV / FCF	25.4x	25.5x	63x	132x	-82.5x	12x	18.3x	14.9x
FCF Yield	3.94%	3.92%	1.59%	0.76%	-1.21%	8.36%	5.45%	6.69%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	1.98	2.16	0.84	-0.09	-6.74	0.64	1.245	1.625
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	1,542	1,558	1,542	1,611	1,635	1,674	1,728	1,786
EBITDA ¹	400.7	411.3	369.7	322.2	317.5	344.3	363	385.9
EBIT ¹	314.1	366.6	329.1	281.1	274.8	297.6	315.9	336.3
Net income ¹	169.1	180.6	67.74	-6.944	-516.5	42.03	78.69	100.4
Net Debt ¹	1,033	986.7	1,200	1,535	1,596	1,489	1,285	1,064
Reference price ²	66.99	56.07	43.55	22.68	12.42	16.02	16.02	16.02
Nbr of stocks (in thousands)	84,700	83,518	78,176	77,164	77,892	77,773	-	-
Announcement Date	2/23/22 A	2/22/23 A	2/28/24 A	2/25/25 A	2/26/26 A	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
INTEGRA LIFESCIENCES HOLDINGS CORPORATION	25.03x	1.63x	7.94x	-.--%	1.25B
ABBOTT LABORATORIES	29.38x	4.05x	15.66x	2.48%	179B
MEDTRONIC PLC	19.2x	3.51x	12.56x	3.1%	116B
CENCORA, INC.	17.22x	0.2x	12.61x	0.76%	60B
BECTON, DICKINSON AND COMPANY	35.27x	3.41x	11.68x	2.14%	49.85B
HOYA CORPORATION	27.56x	6.78x	17.54x	1.45%	48.05B
DEXCOM, INC.	35.89x	6.31x	19.82x	-.--%	33.79B
MEDLINE INC.	44.45x	1.29x	11.95x	0.21%	30.21B
WEST PHARMACEUTICAL SERVICES, INC.	43.27x	7.59x	27.23x	0.24%	26.12B
SARTORIUS STEDIM BIOTECH	52.64x	7.06x	22.71x	0.4%	22.98B
Average	32.99x	4.19x	15.97x	1.08%	56.78B
Weighted average by Cap.	29.13x	3.98x	15.36x	1.85%